Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Clinical Application of Image-Guided Liver Surgery
Clinical Application of Image-Guided Liver Surgery
Status: Enrolling
Updated:  1/16/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Clinical Application of Image-Guided Liver Surgery
Clinical Application of Image-Guided Liver Surgery
Status: Enrolling
Updated: 1/16/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Predicting Response to Platinum Chemotherapy in Metastatic Castration Resistant Prostate Ca(mCRPC)Using a Genomic Signature for "BRCAness": A Phase II Prospective Open Label Clinical Trial of Satraplatin in Men With mCRPC Who Have Progressed on Docetaxel
Status: Enrolling
Updated:  1/16/2018
Mount Sinai Hospital
mi
from
New York, NY
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Predicting Response to Platinum Chemotherapy in Metastatic Castration Resistant Prostate Ca(mCRPC)Using a Genomic Signature for "BRCAness": A Phase II Prospective Open Label Clinical Trial of Satraplatin in Men With mCRPC Who Have Progressed on Docetaxel
Status: Enrolling
Updated: 1/16/2018
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
Phase II Trial Evaluating the Safety and Efficacy of Atorvastatin for the Prophylaxis of Acute Graft Versus Host Disease(GVHD) in Patients With Hematological Malignancies Undergoing HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated:  1/16/2018
Ohio State University
mi
from
Columbus, OH
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
Phase II Trial Evaluating the Safety and Efficacy of Atorvastatin for the Prophylaxis of Acute Graft Versus Host Disease(GVHD) in Patients With Hematological Malignancies Undergoing HLA-Matched Related Donor Hematopoietic Stem Cell Transplantation (HSCT)
Status: Enrolling
Updated: 1/16/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer
Intratumoral Genetic Therapy for Lung Cancer
Status: Enrolling
Updated:  1/16/2018
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer
Intratumoral Genetic Therapy for Lung Cancer
Status: Enrolling
Updated: 1/16/2018
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Georgetown University Hospital, Department of Radiology
mi
from
Washington,
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Georgetown University Hospital, Department of Radiology
mi
from
Washington,
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Cleveland Clinic, Breast Services DDI Clinical Research
mi
from
Cleveland, OH
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Cleveland Clinic, Breast Services DDI Clinical Research
mi
from
Cleveland, OH
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
MD Anderson Cancer Center, Department of Radiology and Breast Imaging
mi
from
Houston, TX
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
MD Anderson Cancer Center, Department of Radiology and Breast Imaging
mi
from
Houston, TX
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Univ. Texas Health Science Center at San Antontio, Breast Imaging Center at the Cancer Therapy Research Center
mi
from
San Antonio, TX
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Univ. Texas Health Science Center at San Antontio, Breast Imaging Center at the Cancer Therapy Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Radnet (Temecula)
mi
from
Murrieta, CA
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Radnet (Temecula)
mi
from
Murrieta, CA
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Sally Jobe
mi
from
Englewood, CO
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Sally Jobe
mi
from
Englewood, CO
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Yale University
mi
from
New Haven, CT
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Boca Raton Regional Hospital
mi
from
Boca Raton, FL
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Boca Raton Regional Hospital
mi
from
Boca Raton, FL
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Breast Care Atlanta
mi
from
Atlanta, GA
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Breast Care Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Northwestern University
mi
from
Chicago, IL
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
New York-Presbyterian Hospital
mi
from
New York, NY
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Elizabeth Wende Breast Care
mi
from
Rochester, NY
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Elizabeth Wende Breast Care
mi
from
Rochester, NY
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Solis Women's Health (North Carolina)
mi
from
Greensboro, NC
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Solis Women's Health (North Carolina)
mi
from
Greensboro, NC
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Weinstein Imaging Associates
mi
from
Pittsburgh, PA
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Weinstein Imaging Associates
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Austin Radiological Association
mi
from
Austin, TX
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Austin Radiological Association
mi
from
Austin, TX
Click here to add this to my saved trials
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated:  1/16/2018
Solis Women's Health
mi
from
Plano, TX
The PIONEER-0 Study of the Imagio Breast Imaging System
A Study of Imaging With Opto-acoustics to Diagnose Breast Masses Detected by Mammography and/or Diagnostic Ultrasound: A New Evaluation Tool for Radiologists
Status: Enrolling
Updated: 1/16/2018
Solis Women's Health
mi
from
Plano, TX
Click here to add this to my saved trials
A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation
A Comparative Study of the Physiological Response, Between AirSeal, an Integrated Insufflation and Access System, and Conventional Insufflation and Trocars
Status: Enrolling
Updated:  1/16/2018
University of California, Irvine Medical Center
mi
from
Orange, CA
A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation
A Comparative Study of the Physiological Response, Between AirSeal, an Integrated Insufflation and Access System, and Conventional Insufflation and Trocars
Status: Enrolling
Updated: 1/16/2018
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Study of Intravenous RXDX-107 in Patients With Solid Tumors
A Phase 1/1b, Multicenter, Open-Label Study of Intravenous RXDX-107 in Adult Patients With Locally Advanced or Metastatic Solid Cancer
Status: Enrolling
Updated:  1/16/2018
Florida Cancer Specialists
mi
from
Sarasota, FL
Study of Intravenous RXDX-107 in Patients With Solid Tumors
A Phase 1/1b, Multicenter, Open-Label Study of Intravenous RXDX-107 in Adult Patients With Locally Advanced or Metastatic Solid Cancer
Status: Enrolling
Updated: 1/16/2018
Florida Cancer Specialists
mi
from
Sarasota, FL
Click here to add this to my saved trials
Study of Intravenous RXDX-107 in Patients With Solid Tumors
A Phase 1/1b, Multicenter, Open-Label Study of Intravenous RXDX-107 in Adult Patients With Locally Advanced or Metastatic Solid Cancer
Status: Enrolling
Updated:  1/16/2018
Johns Hopkins Medical Institute
mi
from
Baltimore, MD
Study of Intravenous RXDX-107 in Patients With Solid Tumors
A Phase 1/1b, Multicenter, Open-Label Study of Intravenous RXDX-107 in Adult Patients With Locally Advanced or Metastatic Solid Cancer
Status: Enrolling
Updated: 1/16/2018
Johns Hopkins Medical Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Intravenous RXDX-107 in Patients With Solid Tumors
A Phase 1/1b, Multicenter, Open-Label Study of Intravenous RXDX-107 in Adult Patients With Locally Advanced or Metastatic Solid Cancer
Status: Enrolling
Updated:  1/16/2018
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Study of Intravenous RXDX-107 in Patients With Solid Tumors
A Phase 1/1b, Multicenter, Open-Label Study of Intravenous RXDX-107 in Adult Patients With Locally Advanced or Metastatic Solid Cancer
Status: Enrolling
Updated: 1/16/2018
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
Status: Enrolling
Updated:  1/16/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma
Status: Enrolling
Updated: 1/16/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
Status: Enrolling
Updated:  1/17/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
Status: Enrolling
Updated: 1/17/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
City of Hope
mi
from
Duarte, CA
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
Yale Smilow Cancer Center
mi
from
New Haven, CT
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
Yale Smilow Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
Women and Infants Hospital
mi
from
Providence, RI
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
Women and Infants Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
Roger Williams Medical Center
mi
from
Providence, RI
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
Roger Williams Medical Center
mi
from
Providence, RI
Click here to add this to my saved trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated:  1/17/2018
Rhode Island and The Miriam Hospital
mi
from
Providence, RI
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer
BrUOG-BR-211B q3week Carboplatin With Weekly Abraxane and Trastuzumab As Neoadjuvant Therapy in Resectable and Unresectable HER2+ (Stage IIa-IIIb) Breast Cancer
Status: Enrolling
Updated: 1/17/2018
Rhode Island and The Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Phase I Trial of Intraperitoneal Nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Status: Enrolling
Updated:  1/17/2018
Swedish Medical Center
mi
from
Seattle, WA
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Phase I Trial of Intraperitoneal Nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Status: Enrolling
Updated: 1/17/2018
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Phase I Trial of Intraperitoneal Nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Status: Enrolling
Updated:  1/17/2018
City of Hope Medical Center
mi
from
Duarte, CA
Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Phase I Trial of Intraperitoneal Nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Status: Enrolling
Updated: 1/17/2018
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
Moores University of California San Diego Cancer Center
mi
from
La Jolla, CA
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
Moores University of California San Diego Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
University of Chicago
mi
from
Chicago, IL
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
State University of New York Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
Rhode Island Hospital
mi
from
Providence, RI
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
University of Vermont
mi
from
Burlington, VT
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase I Study of Accelerated Hypofractionated Radiation Therapy With Concomitant Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
A Randomized, Placebo Controlled-Double Blind Study of Minocycline for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer
Status: Enrolling
Updated:  1/17/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
A Randomized, Placebo Controlled-Double Blind Study of Minocycline for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer
Status: Enrolling
Updated: 1/17/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated:  1/17/2018
Norris Comprehensive Cancer Center- University of Southern California
mi
from
Los Angeles, CA
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated: 1/17/2018
Norris Comprehensive Cancer Center- University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated:  1/17/2018
University of Florida Shands Cancer Center
mi
from
Gainesville, FL
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated: 1/17/2018
University of Florida Shands Cancer Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated:  1/17/2018
Georgia Health Sciences University
mi
from
Augusta, GA
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated: 1/17/2018
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated:  1/17/2018
University of Chicago
mi
from
Chicago, IL
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated: 1/17/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated:  1/17/2018
Melvin and Bren Simon Cancer Center- Indiana University
mi
from
Indianapolis, IN
SGI-110 in Combination With Carboplatin in Ovarian Cancer
A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer
Status: Enrolling
Updated: 1/17/2018
Melvin and Bren Simon Cancer Center- Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials